Quantum Leap Healthcare Collaborative

Media Center

Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
Close
Close
I-SPY Email List Sign-up

Latest Press Release

Media Contact: 
    Jeff Matthews, PhD
    UCSF
    jmatthews@ispy2.org

Backgrounders

August 30, 2018
Patient Story: Why I chose I-SPY 2
A patient's perspective on participating in the I-SPY 2 TRIAL.
August 30, 2018
Patient Story: My experience as an I-SPY 2 patient
A patient's perspective on participating in the I-SPY 2 TRIAL.
August 30, 2018
I-SPY 2 Patient Brochure
Introductory information on the I-SPY 2 TRIAL.
August 30, 2018
Executive Summary: the I-SPY 2 TRIAL
Some history of the I-SPY TRIAL